San Diego, CA (PRWEB) August 04, 2016
David Hale has been involved in the life science industry for decades in San Diego and has now launched a new company, Adigica Health, Inc., formed to develop and commercialize specialty healthcare and skincare products directly to consumers. Mr. Hale is no stranger to the skin care and dermatology market, having served as Chairman of SkinMedica from 2001 until its sale to Allergan in 2014. Hale also has been a founder and/or chairman of other skincare and dermatology companies including MDRejuvena, ColoreScience, Dermata Therapeutics, Skylit Medical and Recros Medica.
In other areas of life sciences, Hale has been a co-founder/CEO and/or chairman at Hybritech, Gensia. Viagene, CancerVax, Santarus, Micromet, Crisi Medical, BIOCEPT, Conatus and Neurelis.
Mr. Hale is also a well-known civic leader in San Diego. He is a co-founder, former chairman and serves on the Board of Directors of BIOCOM and CONNECT and is a former member of the Board of the Biotechnology Industry Organization (BIO). He served as Chairman of the Board of Trustees of Rady Children’s Hospital and is now Chairman of the Board of the Rady Institute of Pediatric Genomics at Rady Children’s. Hale serves on The Salk Institute Board of Trustees, is a member of the Rady School of Management Dean’s Advisory Council, and is a Director and former chairman of the San Diego Economic Development Corporation.
Mr. Hale has teamed up with Rick Sliter, President and CEO of Adigica Health. Mr. Sliter is a former senior executive with Provide Commerce, the San Diego based e-commerce company that built ProFlowers® and Shari’s Berries® into major consumer brands. The Board of Adigica Health includes Cam Garner, a longtime serial healthcare entrepreneur; Bill Strauss, former CEO of Provide Commerce; and Howard Palefsky, former venture capitalist and healthcare executive. The Adigica Health team includes former ecommerce executives as well as additional healthcare and social media professionals.
This week Adigica Health announced the launch of BioClarity™, a new proprietary skincare regimen specifically formulated for the treatment of acne in teenagers and young adults.
The BioClarity™ regimen was formulated by research scientists to include salicylic acid, a proven treatment for acne, combined with natural ingredients including a patented and proprietary ingredient, Floralux™. Floralux™ is a naturally derived ingredient from chlorophyll (the green material in plants), that helps reduce the symptoms of acne and the side effects of acne medications, plus helps to restore the natural balance of the skin.
In a clinical trial of BioClarity™ in teenagers and young adults, patients used BioClarity™ for eight weeks. After the trial period, 90% of users reported a favorable reduction in the number of blemishes, while 87% saw an overall improvement in the appearance of their skin and 90% of participants said that they would recommend or strongly recommend BioClarity™ to other acne sufferers.
“We developed BioClarity™ based on our significant experience in skincare and the belief that we could develop an acne treatment regimen especially formulated for the skin of teenagers and young adults. We believe that the BioClarity™ regimen will be well accepted because it produces significant positive results,” said David Hale.
“We are very excited to offer BioClarity™ directly to millions of teenagers and young adults who suffer from acne, which can be both socially and physically challenging. We believe that our formulation of natural ingredients and proven acne fighting medication will make BioClarity™ the product of choice for acne treatment in this target patient group,” said Mr. Sliter. “I’m personally thrilled to launch a new ecommerce business in San Diego leveraging the incredible biotech, life science and e-commerce expertise in our city.”
For more information and to purchase BioClarity™, visit http://www.BioClarity.com. BioClarity™, Floralux™ and Adigica Health are trademarks of Adigica Health, Inc.
Adigica Health is an e-commerce healthcare company focused on the development and commercialization of proprietary healthcare products directly to consumers. The Company’s initial flagship product, BioClarity™, has been especially formulated to treat acne in teenagers and young adults.